$NRXP entry PT 8.50-9 Long term PTs 40-50 and higher
WAVE ANALYSIS
SUPPORT AND RESISTANCE
NRX Pharmaceuticals, Inc., a clinical-stage small molecule pharmaceutical company, develops various therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company's pipeline includes medicinal candidates in Phase 2 and...
Fib Retracement on NRXP doesn't show much by way of "important levels" until you get to the 786 if you use that ATH for the top of your fib set-up. BUT if you look back on the chart, there's a pretty clear level right AT the area NRXP stock is trading at after this news. Around $12.70 was a previous area where the stock tested but didn't break below. Now, since...
NRXP is reaching its 52week low and what goes down must go up & vice-versa in the market...the long wick inverted candle looks like this may have some momentum on the upside if the phase 2 and 3 trials go well for is COVID-19 lung respiratory issues and Bipolar acute suicide medication will be useful for both mental and physiological health...stochastic looks like...
